Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Jarratt Pytell to Humans

This is a "connection" page, showing publications Jarratt Pytell has written about Humans.

 
Connection Strength
  
 
 
0.379
  
  1. Pytell JD, Fiellin DA. Post Void Residuals: Medications for Opioid Use Disorder, Patient Outcomes, and How Not to Get Fooled by Urine Toxicology Results. J Addict Med. 2025 May-Jun 01; 19(3):242-244.
    View in: PubMed
    Score: 0.025
  2. Pytell JD, Christine PJ, LeMasters K, Rockhill KM, Black JC, Dart RC, Binswanger IA. Comparison of heroin and fentanyl use in US nationally representative surveys. Addict Sci Clin Pract. 2025 Feb 11; 20(1):13.
    View in: PubMed
    Score: 0.025
  3. Pytell JD, Narwaney KJ, Nguyen AP, Glanz JM, Binswanger IA. New Alcohol-related Condition Diagnoses Are Associated With Opioid Tapers Among Patients Receiving Long-term Opioid Therapy. J Addict Med. 2025 May-Jun 01; 19(3):290-297.
    View in: PubMed
    Score: 0.024
  4. Pytell JD, Binswanger IA. Addressing Opioid Use Disorder in Primary Care: Revisiting Core Primary Care Principles to Confidently Initiate Treatment. J Gen Intern Med. 2024 Jul; 39(9):1749-1750.
    View in: PubMed
    Score: 0.023
  5. Pytell JD, Fojo AT, Keruly JC, Snow LN, Falade-Nwulia O, Moore RD, Chander G, Lesko CR. Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use. Addict Sci Clin Pract. 2023 09 02; 18(1):51.
    View in: PubMed
    Score: 0.022
  6. Pytell JD, Rubenstein LV. So What Do We Do Now? New Opioid Prescribing Guidelines, Implementation Science, and How to Improve the Care of Patients Receiving Long-Term Opioid Therapy in Primary Care. J Gen Intern Med. 2023 06; 38(8):1791-1793.
    View in: PubMed
    Score: 0.022
  7. Pytell JD, Whitley P, Passik SD, Bundy WL, Dawson E, Saloner B. Association of Patients' Direct Addition of Buprenorphine to Urine Drug Test Specimens With Clinical Factors in Opioid Use Disorder. JAMA Psychiatry. 2023 05 01; 80(5):459-467.
    View in: PubMed
    Score: 0.022
  8. Pytell JD, Chander G, Thakrar AP, Ogunwole SM, McGinty EE. Does a Survivorship Model of Opioid Use Disorder Improve Public Stigma or Policy Support? A General Population Randomized Experiment. J Gen Intern Med. 2023 05; 38(7):1638-1646.
    View in: PubMed
    Score: 0.021
  9. Pytell JD, Thakrar AP, Chander G, Colantuoni E. Changes in Alcohol Consumption by Beverage Type Attributable to the COVID-19 Pandemic for 10 States, March 2020 to November 2020: An Ecological Simulation-based Analysis. J Addict Med. 2022 Nov-Dec 01; 16(6):e412-e416.
    View in: PubMed
    Score: 0.021
  10. Pytell JD, Shen NM, Keruly JC, Lesko CR, Lau B, Fojo AT, Baum MK, Gorbach PM, Javanbakht M, Kipke M, Kirk GD, Mustanski B, Shoptaw S, Siminski S, Moore RD, Chander G. The relationship of alcohol and other drug use during the COVID-19 pandemic among people with or at risk of HIV; A cross-sectional survey of people enrolled in Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) cohorts. Drug Alcohol Depend. 2022 12 01; 241:109382.
    View in: PubMed
    Score: 0.020
  11. Pytell JD, Sklar MD, Carrese J, Rastegar DA, Gunn C, Chander G. "I'm a Survivor": Perceptions of Chronic Disease and Survivorship Among Individuals in Long-Term Remission from Opioid Use Disorder. J Gen Intern Med. 2022 02; 37(3):593-600.
    View in: PubMed
    Score: 0.019
  12. Pytell JD, Rastegar DA. Down the drain: Reconsidering routine urine drug testing during the COVID-19 pandemic. J Subst Abuse Treat. 2021 01; 120:108155.
    View in: PubMed
    Score: 0.018
  13. Pytell JD, Sharfstein JM, Olsen Y. Additional Barriers to Methadone Use in Hospitals and Skilled Nursing Facilities-Reply. JAMA Intern Med. 2020 04 01; 180(4):615.
    View in: PubMed
    Score: 0.018
  14. Pytell JD, Sharfstein JM, Olsen Y. Facilitating Methadone Use in Hospitals and Skilled Nursing Facilities. JAMA Intern Med. 2020 01 01; 180(1):7-8.
    View in: PubMed
    Score: 0.017
  15. Pytell JD, Buresh ME, Graddy R. Outcomes of a novel office-based opioid treatment program in an internal medicine resident continuity practice. Addict Sci Clin Pract. 2019 12 19; 14(1):46.
    View in: PubMed
    Score: 0.017
  16. Pytell JD, Rastegar DA. Who Leaves Early? Factors Associated With Against Medical Advice Discharge During Alcohol Withdrawal Treatment. J Addict Med. 2018 Nov/Dec; 12(6):447-452.
    View in: PubMed
    Score: 0.016
  17. Campopiano von Klimo M, Nolan L, Corbin M, Farinelli L, Pytell JD, Simon C, Weiss ST, Compton WM. Physician Reluctance to Intervene in Addiction: A Systematic Review. JAMA Netw Open. 2024 07 01; 7(7):e2420837.
    View in: PubMed
    Score: 0.006
  18. Hwang YJ, Lesko CR, Brown TT, Alexander GC, Zalla LC, Keruly JC, Snow LN, Pytell JD, Falade-Nwulia O, Jones JL, Moore RD, Fojo AT. Association between switching to integrase strand transfer inhibitors and incident diabetes in people with HIV. AIDS. 2024 Sep 01; 38(11):1696-1702.
    View in: PubMed
    Score: 0.006
  19. Verinumbe T, Lesko CR, Moore RD, Fojo AT, Keruly J, Snow LN, Hutton H, Chander G, Pytell JD, Falade-Nwulia O. The association of changes in depression severity after the onset of the COVID-19 pandemic and viral nonsuppression among people with HIV. AIDS. 2024 05 01; 38(6):887-894.
    View in: PubMed
    Score: 0.006
  20. Lesko CR, Falade-Nwulia OO, Pytell JD, Hutton HE, Fojo AT, Keruly JC, Moore RD, Chander G. Joint effects of substance use disorders and recent substance use on HIV viral non-suppression among people engaged in HIV care in an urban clinic, 2014-2019. Addiction. 2023 11; 118(11):2193-2202.
    View in: PubMed
    Score: 0.006
  21. Thakrar AP, Pytell JD, Stoller KB, Walters V, Weiss RD, Chander G. Transitioning off methadone: A qualitative study exploring why patients discontinue methadone treatment for opioid use disorder. J Subst Use Addict Treat. 2023 07; 150:209055.
    View in: PubMed
    Score: 0.005
  22. Lesko CR, Keruly JC, Moore RD, Shen NM, Pytell JD, Lau B, Fojo AT, Mehta SH, Kipke M, Baum MK, Shoptaw S, Gorbach PM, Mustanski B, Javanbakht M, Siminski S, Chander G. COVID-19 and the HIV continuum in people living with HIV enrolled in Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) cohorts. Drug Alcohol Depend. 2022 12 01; 241:109355.
    View in: PubMed
    Score: 0.005
  23. Levander XA, Pytell JD, Stoller KB, Korthuis PT, Chander G. COVID-19-related policy changes for methadone take-home dosing: A multistate survey of opioid treatment program leadership. Subst Abus. 2022; 43(1):633-639.
    View in: PubMed
    Score: 0.005
  24. Callan J, Pytell J, Ross J, Rastegar DA. Transition From Methadone to Buprenorphine Using a Short-acting Agonist Bridge in the Inpatient Setting: A Case Study. J Addict Med. 2020 Sep/Oct; 14(5):e274-e276.
    View in: PubMed
    Score: 0.005
  25. Painter JE, Walker AT, Pytell J, Nua MT, Soliai-Lemusu S, Mintz E, Ali I, Parsons M, Martin H, Beach M, Bowen A, Cope J. Notes from the field: outbreak of diarrheal illness caused by Shigella flexneri - American Samoa, May-June 2014. MMWR Morb Mortal Wkly Rep. 2015 Jan 16; 64(1):30.
    View in: PubMed
    Score: 0.003
  26. Carriere SP, Pytell JD, Saltzman AF, Fuselier HA. Peyronie's Disease: A Historical Perspective. Am J Mens Health. 2014 Sep; 8(5):434-9.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)